Eight years after La Caisse made FNZ a flagship patient capital investment, repeated equity injections and a deeper governance role are putting pressure on the advantages of long-term direct ownership. The next phase will show whether that patience has preserved value or merely extended the turnaround.FNZ's shareholders have put US$2.6...